SATKARTAR
Sat Kartar
Pharmaceuticals · ₹312 Cr market cap
An Ayurveda healthcare company that delivers natural wellness solutions through therapeutic and lifestyle products grounded in traditional Indian medicine. Incorporated in 2012, the company specializes in plant-based formulations designed for health management and wellness across diverse consumer segments. It operates in the growing natural healthcare sector, serving customers who seek traditional remedies and preventive wellness solutions in India's expanding wellness market.
1
Tracked investors holding
1
Tracked moves
₹135
Share price
Latest activity
Recent moveIncreased
Promoter Manprit Singh Chadha increased his stake in Sat Kartar from 20.94% to 23.63% by purchasing 4,24,220 shares for ₹7.08 Cr at ₹167.00 apiece.
Top investors holding Sat Kartar
1.88%